TrialPloS one2020

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis.

Arthur S Waldbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.